Navigation Links
Heptares to Present at Upcoming Scientific and Biotech Industry Conferences
Date:4/16/2013

WELWYN GARDEN CITY, England and BOSTON, April 16, 2013 /PRNewswire/ --

Heptares Therapeutics, the leading GPCR drug discovery company, notes that it will be presenting at the following scientific conferences and biotech industry events over the coming weeks.

8th Annual Drug Discovery Chemistry (San Diego, CA, USA, April 16-18)

Dr Rob Cooke , Heptares' Head of Biomolecular Structure, will give a presentation entitled "Utilizing Structural Insights in GPCR Drug Discovery" as part of the GPCR-Based Drug Design stream (2:40pm, 17 April). Dr Cooke will also be hosting an evening workshop on "Practical Aspects of Structure-based Drug Discovery with GPCRs" at the meeting.

2013 BIO International Convention (22-25 April, Chicago, IL, USA)

Mr Dan Grau (President) will present an overview of the Company during the BioBusiness Forum, which takes place from 8:00am-11:00am on 24 April. Dr Barry Kenny (Chief Business Officer) and Dr Cath Hutchings (Antibody Discovery & Strategic Partnering) will also be present at the event.

4th GPCR Colloquium  at The American Society for Pharmacology and Experimental Therapeutics (ASPET) meeting (Boston, MA, USA, 24-25 April)

Dr Fiona Marshall , Heptares' Chief Scientific Officer, will present a talk entitled "X-ray Structures for the Predictive Generation of GPCR Drugs" (2:15pm, 25 April).

6th Annual Diabetes Summit (29-30 April, Boston, MA, USA)

Mr Dan Grau , Heptares' President, will participate in two panel discussions as part of the Diabetes Partnering and Deal Making stream: the panels are entitled "Innovative Partnering & Licensing Strategies" (3:30pm, 29 April) and "Type 2 Diabetes Innovation" (10:20am, 30 April).

Gordon Research Conference on Molecular Pharmacology (28 April-3 May, Lucca, Italy)

Dr Kaspar Hollenstein , Senior Scientist at Heptares, will give a presentation entitled "Using Thermostabilized Receptors to Obtain Crystal Structures of Family A and Family B G protein-coupled Peptide Receptors" (7:00pm, 1 May).

For a full list of events at which Heptares will be present, please visit http://www.heptares.com

About Heptares Therapeutics

Heptares creates new medicines targeting clinically important, yet historically challenging, GPCRs (G protein-coupled receptors), a superfamily of drug receptors linked to a wide range of human diseases. Leveraging our advanced structure-based drug design technology platform, we have built an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including Alzheimer's disease, Parkinson's disease, schizophrenia, migraine and diabetes. Our pharmaceutical partners include Shire, Cubist, Takeda, MorphoSys, AstraZeneca and MedImmune, and we are backed by MVM Life Science Partners, Clarus Ventures, Novartis Venture Fund and Takeda Ventures. To learn more about Heptares, please visit http://www.heptares.com.


'/>"/>
SOURCE Heptares Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Heptares Grants Shire an Exclusive Worldwide Licence to Develop and Commercialise Novel Drug Candidate for CNS Disorders
2. Heptares Solves First Family B GPCR Structure
3. Heptares to Present at BIO-Europe 2012
4. Heptares to Moderate Panel on Rare Diseases at BBC New York CEO Meeting (13-14 February)
5. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
6. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
7. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
8. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
9. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
10. Masimo to Present at 23rd Annual Piper Jaffray Health Care Conference
11. Biocept and Academic Collaborators to Present Posters at San Antonio Breast Cancer Symposium on Circulating Tumor Cells (CTCs)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... ... May 24, 2017 , ... Today, the South Davis ... Advanced Biological Nutrient Recovery (ABNR™) technology at its 4,000,000 gallon per day South ... to sustainably meet current and future nutrient discharge regulations. The ABNR platform, which ...
(Date:5/24/2017)... Ebola resurfaces in the Democratic Republic of Congo ... reported, a new analysis of the Ebola gene polymerase Replikin ... 2014 and 2017 outbreaks of the disease.  ... the 2014 outbreak. An analysis of the latest data showed ... which again precedes the current outbreak in the DRC. Sequence ...
(Date:5/23/2017)... ... 2017 , ... Genedata, a leading provider of advanced software ... a strong presence at Bio-IT World Conference & Expo 2017 in Boston, MA. ... all attendees to view posters on the entire range of Genedata software ...
(Date:5/23/2017)... ... May 23, 2017 , ... Energetiq Technology, ... announced a facility expansion to accommodate its rapid growth. , The renovations at ... and renovation of the existing areas. The expansion includes, a state-of-the-art engineering facility, ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 ... Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video ... and Region - Global Forecast to 2022", published by ... in 2016 and is projected to reach USD 75.64 ... 2017 and 2022. The base year considered for the ...
(Date:3/23/2017)... 2017 The report "Gesture Recognition and Touchless Sensing Market ... - Global Forecast to 2022", published by MarketsandMarkets, the market is expected to ... between 2017 and 2022. Continue Reading ... ... ...
(Date:3/22/2017)... LIVERMORE, Calif. , March 21, 2017 ... recognition analytics company serving law enforcement agencies, announced today ... Sheridan as director of public safety business development. ... of diversified law enforcement experience, including a focus on ... Vigilant. In his most recent position, Mr. Sheridan served ...
Breaking Biology News(10 mins):